Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam via SipNose for pediatric procedural sedation
NCT03635398Unknown
- Sponsor
- Rabin Medical Center
- Start
- Aug 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of midazolam in Procedural anxiety and Procedural sedation (PS) (3 arms), sponsored by Rabin Medical Center. Primary endpoints: Anxiety level at 60 months and Sedation level at 60 months. Status: unknown.
02
Drugs
midazolam
03
Conditions
Procedural anxietyProcedural sedation (PS)
Beyond the preview
Go deeper on NCT03635398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03635398.